Home

Bellevue Group reported a 5.4% stake in Celldex Therapeutics CLDX · 3,617,669 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
5.4%
Last report
First report
Shares held
3,617,669 sh
Class
Common Stock
Event date
25/08/18
Filed
25/11/14

First 5%+ report · 5.4% stake

Celldex Therapeutics trades, last 26 weeks

What else happened in Celldex Therapeutics around then

Filed or reported within 30 days of the trade day · 25/07/19~25/09/17

Bellevue Group's other 5% stake reports

  • Bellevue Group

    5% stakeJade Biosciences

    5% stake

    Filed 08/14

  • Bellevue Group

    5% stakeViridian Therapeutics, Inc.\DE

    6.6% stake

    Filed 05/15

  • Bellevue Group

    5% stakeCelldex Therapeutics

    1.5% stake

    Filed 05/15

  • Bellevue Group

    5% stakeJade Biosciences

    6.8% stake

    Filed 02/17

  • Bellevue Group

    5% stakeMacrogenics

    0% stake

    Filed 01/06